Dorothy Martinez is an Endocrinology/Metabolic physician affiliated with University of California, Los Angeles. OpenAlex indexes 38 publications with 647 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Medical Plz
#365,420,530,120
Los Angeles, CA 900950001
Telephone
310-825-7922Registry record last updated 10 Mar 2010.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
62.7%Insulin Analog22.4%Lantus Solostar30%Novolog Flexpen17%Humalog Kwikpen U-10011%Basaglar Kwikpen U-10010%Insulin Lispro Kwikpen U-1006%Tresiba Flextouch U-1006%Humalog5%Lantus4%Levemir Flexpen4%Fiasp Flextouch3%Insulin Lispro2%Novolog2%Part D<11 patientsBiguanide (metformin)14.3%Metformin Hcl55%Metformin Hcl Er45%Part D≥64 patients+ 6 more classes in this area
Hormonal (systemic)
28.4%l-Thyroxine25.5%Levothyroxine Sodium65%Synthroid33%Tirosint2%Part D<11 patientsThyroid Hormone Synthesis Inhibitor1.4%Methimazole100%Part D≥13 patients+ 2 more classes in this area
Cardiovascular
7.7%Statin3%Atorvastatin Calcium76%Simvastatin24%Part D<11 patientsACE inhibitor1.9%Benazepril Hcl51%Lisinopril49%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- #1392 Effective interventions to manage the impact of climate change on cardio-renal health: a systematic literature review
Nephrology Dialysis Transplantation
2025 - A Case of Nonislet Cell Tumor Hypoglycemia Due to Metastatic Salivary Myoepithelial Carcinoma
AACE Clinical Case Reports
2024 - Mechanical and electrical uncoupling: the role of cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy proof of concept
European Heart Journal Acute Cardiovascular Care
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Gregg Fonarow, MD
University of California, Los Angeles
Dennis Slamon, MD
University of California, Los Angeles
Tomas Ganz, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”